Bloomberg BNA interviewed Matthew Wall for “Canada Issues Memorandum on Update To OECD’s Transfer Pricing Guidelines.”
Bloomberg BNA quoted Matthew Wall at the OECD Public Consultation for “Andrus Cites ‘Inconsistent’ Business Stances On Weight of Legal Agreements, Comparables.”
Transfer Pricing Week interviewed Matthew Wall for “CRA memorandum endorses OECD method selection.”
MDW explained the CRA’s latest Transfer Pricing Memo (TPM-14) for updating the Information Circular 87-2R on Transfer Pricing to include the latest revisions to the OECD Guidelines including the “most appropriate method in the circumstances”, use of profit methods, comparability …
Bloomberg BNA quoted Matthew Wall at the OECD for “OECD’s Andrus Defends Logic Of MOUs for Bilateral Safe Harbors.”
Bloomberg BNA interviewed Matthew Wall for “Glaxo Remanded to Canada’s Tax Court; Supreme Court Sets New Pricing Framework.”
The OECD invited Matthew Wall of MDW to present at, and participate in, the Public Consultation on the discussion drafts for intangibles, safe harbours and MOUs, and timing differences.
MDW explained the Supreme Court dismissal in GlaxoSmithKline Inc. v. The Queen, sending it back to the Tax Court to include “embedded intangibles” in the price of the active ingredient.
Transfer Pricing Week interviewed Matthew Wall for “GSK Canada Supreme Court decision analysis.”
International Tax Review quoted Matthew Wall of MDW in “What you need to know about the OECD’s recent TP reports.”